The roles and mechanisms of epigenetic regulation in pathological myocardial remodeling

Kun Zhao1, Yukang Mao1, Yansong Li1

  • 1Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Insights

Epigenetic modifications like DNA methylation and RNA modification play crucial roles in pathological myocardial remodeling, a leading cause of death. Understanding these epigenetic mechanisms offers potential new therapeutic targets for heart disease.

Area of Science:

  • Cardiovascular Science
  • Epigenetics
  • Molecular Biology

Background:

  • Pathological myocardial remodeling is a major global health concern with limited treatment options.
  • Epigenetic alterations are increasingly recognized as significant contributors to cardiovascular diseases.

Purpose of the Study:

  • To review recent advancements in understanding epigenetic regulation in pathological myocardial remodeling.
  • To explore the mechanisms underlying the involvement of various epigenetic factors in cardiac remodeling.

Main Methods:

  • Comprehensive literature review of epigenetic mechanisms in pathological myocardial remodeling.
  • Analysis of studies focusing on DNA methylation, histone modifications, chromatin remodeling, non-coding RNAs, and RNA modifications.

Main Results:

  • Detailed summary of key epigenetic regulatory pathways implicated in myocardial remodeling.
  • Identification of specific epigenetic modifications and their roles in cardiac disease progression.

Conclusions:

  • Epigenetic regulation is a critical determinant of pathological myocardial remodeling.
  • Emerging epigenetic targets hold promise for future therapeutic strategies in cardiovascular medicine.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
23
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Nucleosome Remodeling02:54

Nucleosome Remodeling

Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
9.4K